05-001: Treatment of Acute Lymphoblastic Leukemia in Children

NCT00400946 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

800

Enrollment

OTHER

Sponsor class

Conditions

Drug/Agent Toxicity by Tissue/Organ
Leukemia

Interventions

DRUG: asparaginase
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: dexamethasone
DRUG: dexrazoxane hydrochloride
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: leucovorin calcium
DRUG: mercaptopurine
DRUG: methotrexate
DRUG: methylprednisolone
DRUG: pegaspargase
DRUG: prednisolone
DRUG: therapeutic hydrocortisone
DRUG: vincristine sulfate
RADIATION: radiation therapy

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]